Format

Send to

Choose Destination
Thromb Res. 2013 Aug;132(2):e118-23. doi: 10.1016/j.thromres.2013.06.001. Epub 2013 Jun 25.

Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.

Author information

1
Department of Clinical Laboratory Science, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Abstract

INTRODUCTION:

Inherited antithrombin (AT) deficiency is associated with a predisposition to familial venous thromboembolic disease. We analyzed the AT gene in three unrelated patients with an AT deficiency who developed thrombosis.

MATERIALS AND METHODS:

We analyzed the SERPINC1 gene in three patients. Additionally, we expressed the three mutants in the COS-1 cells and compared their secretion rates and levels of AT activity with those of the wild-type (WT).

RESULTS:

We identified three distinct heterozygous mutations of c.2534C>T: p.56Arginine → Cysteine (R56C), c.13398C>A: p.459Alanine → Aspartic acid (A459D) and c.2703C>G: p.112 Proline → Arginine (P112R). In the in vitro expression experiments, the AT antigen levels in the conditioned media (CM) of the R56C mutant were nearly equal to those of WT. In contrast, the AT antigen levels in the CM of the A459D and P112R mutants were significantly decreased. The AT activity of R56C was decreased in association with a shorter incubation time in a FXa inhibition assay and a thrombin inhibition-based activity test. However, the AT activity of R56C was comparable to that of WT when the incubation time was increased.

CONCLUSIONS:

We concluded that the R56C mutant is responsible for type II HBS deficiency. We considered that the A459D and P112R mutants can be classified as belonging to the type I AT deficiency.

KEYWORDS:

AT; Ala; Alanine; Antithrombin; Antithrombin deficiency; Arg; Arginine; Asp; Aspartic acid; CL; CM; COS-1 cells; Cell lysates; Complementary DNA; Conditioned media; Cys; Cysteine; DVT; Deep vein thrombosis; ELISA; Enzyme-linked immunosorbent assay; FXa; Factor Xa; Green monkey kidney cells; Lys; Lysine; PE; PMSF; Phenylmethyl sulfonylfluoride; Pro; Proline; Pulmonary thromboembolism; RCL; RFLP; Reactive center loop; Restriction fragment length polymorphism analysis; Serine protease inhibitor; Type II heparin binding site defects; Type II reactive site defects; Type II with pleiotropic defects; VTE; Venous thromboembolism; WT; Wild-type; cDNA; factor Xa inhibition activity assay; serpin; thrombin inhibition activity assay; type II HBS; type II PE; type II RS

PMID:
23809926
DOI:
10.1016/j.thromres.2013.06.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center